CHI3L1 and astrocytoma (excluding glioblastoma): Several studies have reported a strong correlation between elevated expression levels of CHI3L1 (YKL40) in the serum of patients with various cancers, including breast, gastrointestinal, liver, prostate, brain, endometrial, and lung cancers, as well as astrocytomas [5,51,54].